Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galephar Pharmaceutical Research
Humacao, Puerto Rico, United States / Puerto Ricogalephar.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Galephar Pharmaceutical Research develops and manufactures oral and pulmonary drug formulations, with proprietary technologies for enhanced bioavailability and controlled release. Its products have reached commercial stage in multiple markets through licensing partners. Notable clinical results include approval of colecalciferol for vitamin D deficiency in Canada, and isotretinoin for severe acne in North/South America[2][7][10].
- Therapeutic areas
- GastroenterologyEndocrinologyDermatology
- Modalities
- Small moleculeOral drug delivery technologyPulmonary drug delivery technology
- Industry
- Biotech
02
Partnerships
Cipher PharmaceuticalsTecnofarma
Beyond the preview
Go deeper on Galephar Pharmaceutical Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Galephar Pharmaceutical Research.